Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
- 9 February 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 280 (5), 1216-1223
- https://doi.org/10.1006/bbrc.2001.4267
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An inventory of the human ABC proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- The multidrug resistance protein familyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistanceBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell LinesJNCI Journal of the National Cancer Institute, 1999
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell lineBritish Journal of Cancer, 1998
- Expression of the UDP-glucuronosyltransferase 1A Locus in Human ColonJournal of Biological Chemistry, 1998
- The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitroJapanese Journal of Cancer Research, 1997
- DX-8951F, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variantInternational Journal of Cancer, 1997